Daily blog desk

Source-linked Type 1 diabetes articles, generated from the live feed.

This is the public face for ongoing content: daily briefings, device safety watches, trial roundups, research watches, and evidence-label explainers. Updated from the same source pipeline that powers the feed.

Daily BriefingClinical TrialsResearch WatchDevice SafetyEditorial Policy

Daily Briefing/October 27, 2026/3 min read

October 27, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

Read today's brief

Химична лаборатория, епруветки. Chemical laboratory, test tubes

Source-backed article

a hospital room with a bed and medical equipment

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 27, 2026 / 10 sources

Young scientist wearing protective gloves and examining a plant sample in a laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 27, 2026 / 12 sources

Healthcare professional using glucometer to check blood sugar level, indicating diabetes management.

Daily Briefing

October 26, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 26, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 26, 2026 / 10 sources

A medical practitioner gently holding a newborn baby in a hospital room, symbolizing care and health.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 26, 2026 / 7 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 26, 2026 / 12 sources

A man in a lab coat and goggles looking through a microscope

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 25, 2026 / 12 sources

Atomic Force Microscope Science Museum London

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 24, 2026 / 12 sources

Precision medical laboratory Eastern Main Road, Tacarigua

Daily Briefing

October 23, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 23, 2026 / 10 sources

A doctor in a face mask consults a patient in a clinic, reflecting the new normal.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 23, 2026 / 10 sources

a close up of a microscope with a purple light

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 23, 2026 / 12 sources

Two scientists working on computers in a laboratory

Daily Briefing

October 22, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 22, 2026 / 10 sources

a doctor checking a patient's blood pressure

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 22, 2026 / 10 sources

A person in white gloves looking through a microscope

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 22, 2026 / 12 sources

Daily Briefing

October 21, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 21, 2026 / 10 sources

A male patient consulting a female Dietician about his diet at the University of Nigeria Medical Centre Nsukka

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 21, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 21, 2026 / 12 sources

European Molecular Biology Laboratory (EMBL) - July 2022 5

Daily Briefing

October 20, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 20, 2026 / 10 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 20, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 20, 2026 / 12 sources

Daily Briefing

October 19, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 19, 2026 / 10 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 19, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 19, 2026 / 12 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 18, 2026 / 12 sources

Ross Marklein, Ph.D., a post-doctoral research fellow at FDA, examines images of stem cells in an FDA laboratory on the National Institutes of Health campus in

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 17, 2026 / 12 sources

Flat lay of diabetes awareness concept with glucose meter, insulin syringes, sugar cubes, and donut.

Daily Briefing

October 16, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 16, 2026 / 10 sources

Heba Degheidy, M.D., Ph.D., a visiting research associate at FDA, works with stem cell samples in an FDA laboratory on the National Institutes of Health campus

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 16, 2026 / 8 sources

Induced Pluripotent Stem Cells of Huntington's Disease

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 16, 2026 / 12 sources

Woman holding an insulin pen, showcasing healthcare and diabetes management in a modern setting.

Daily Briefing

October 15, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 15, 2026 / 10 sources

Single Photon Emission Computed Tomography (SPECT) with circular containment tube at biosafety level 4 (BSL-4) laboratory of the NIAID Integrated Research Facil

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 15, 2026 / 9 sources

Magnetic Resonance Imaging (MRI) with circular containment tube at biosafety level 4 (BSL-4) laboratory of the NIAID Integrated Research Facility (IRF) in Frede

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 15, 2026 / 12 sources

Diabetic Type 1 adult man with insulin pump and CGM sensor

Daily Briefing

October 14, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 14, 2026 / 10 sources

Doctor in white coat checking patient chart in hospital room with medical equipment.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 14, 2026 / 9 sources

Laboratory technician working with a cell

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 14, 2026 / 12 sources

Symbolic image of diabetes prevention message with pineapple and insulin syringes.

Daily Briefing

October 13, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 13, 2026 / 10 sources

Healthcare professional checks temperature with digital thermometer during patient consultation in a medical office undefined

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 13, 2026 / 10 sources

Senior researcher working with a microscope in a laboratory setting, assisted by a colleague.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 13, 2026 / 12 sources

Two female scientists conducting research with microscope in a laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 12, 2026 / 12 sources

Close-up of a glucometer reading 95 mg/dl with a lancing device, ideal for diabetes and healthcare imagery.

Daily Briefing

October 11, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 11, 2026 / 10 sources

A female scientist uses a microscope in a laboratory, focusing on research and analysis.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 11, 2026 / 12 sources

Artistic depiction of red blood cells on a white background, emphasizing medical concepts.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 10, 2026 / 12 sources

Top view of lancets for blood glucose meter placed near glucometer and letter board with World Diabetes Day inscription

Daily Briefing

October 9, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 9, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 9, 2026 / 10 sources

Doctor in consultation with patient at a medical clinic, discussing treatment options.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 9, 2026 / 7 sources

Detailed view of a microscope in a laboratory used in scientific research.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 9, 2026 / 12 sources

High Blood Sugar Readings on Glucose Test Monitoring device

Daily Briefing

October 8, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 8, 2026 / 10 sources

Vaccine research center attached to a Kabul hospital in the 1960s. Original caption: "A laboratory at the Vaccine Research Center."

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 8, 2026 / 10 sources

Close-up of stained plant cells in onion root under microscope.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 8, 2026 / 12 sources

Close-up of a woman's hands holding insulin pens. Perfect for health and diabetes-related content.

Daily Briefing

October 7, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 7, 2026 / 10 sources

A healthcare professional administers an injection to an elderly patient in a hospital setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 7, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 7, 2026 / 12 sources

A comprehensive flat lay of diabetes management tools including a glucose meter and instructional flyers.

Daily Briefing

October 6, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 6, 2026 / 10 sources

British medics help earthquake-hit hospital in Kathmandu, Nepal

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 6, 2026 / 10 sources

A dense cluster of red blood cells floating in a fluid medium

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 6, 2026 / 12 sources

Researchers conducting a scientific experiment with a syringe and petri dish in a lab setting.

Daily Briefing

October 5, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 5, 2026 / 10 sources

A healthcare professional in gloves provides treatment to a patient in a medical setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 5, 2026 / 10 sources

Female scientist using a microscope in a laboratory environment, focusing on research.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 5, 2026 / 12 sources

A cluster of translucent purple cells with glowing pink nuclei on a purple background

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 4, 2026 / 12 sources

A series of microscopes on a lab table, ideal for scientific research and education.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 3, 2026 / 12 sources

A blood glucose meter with a lancing device and test strips on white

Daily Briefing

October 2, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 2, 2026 / 10 sources

A digital glucometer and lancing device on a wooden surface indicating high blood glucose level.

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 2, 2026 / 10 sources

Healthcare professional reviews medical form during patient consultation in a clinic setting.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

October 2, 2026 / 6 sources

Doctor checking patient's vitals in a clinical setting for health consultation.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 2, 2026 / 10 sources

Two scientists in a lab examining samples with a microscope. Focus on scientific research and discovery.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 2, 2026 / 12 sources

A Blood-Glucose-Powered Metabolic Fuel Cell for Self-Sufficient Bioelectronics

Daily Briefing

October 1, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 1, 2026 / 10 sources

File:Blood Pressure And Blood Glucose Test - Health Check-up Camp - NCSM - Salt Lake City - Kolkata 2017-06-21 2950.JPG

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 1, 2026 / 10 sources

A cluster of medical syringes with blue fluid, ideal for healthcare and vaccination themes.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

October 1, 2026 / 6 sources

Khaschuvate Complex of District Hospital Medical Laboratory 01 (YDS 0551)

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 1, 2026 / 8 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 1, 2026 / 12 sources

Medical research setup featuring anatomical models, x-rays, and a textbook, ideal for educational purposes.

Daily Briefing

September 30, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 30, 2026 / 10 sources

File:Blood Pressure And Blood Glucose Test - Health Check-up Camp - NCSM - Salt Lake City - Kolkata 2017-06-21 2947.JPG

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 30, 2026 / 10 sources

Flat lay of blood pressure monitor, pills, and ECG printout for heart health theme.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 30, 2026 / 6 sources

Pensive man nurse in blue uniform standing and demonstrating diagnosis to serious African American female patient in hallway of hospital in daytime

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 30, 2026 / 10 sources

Close-up of labeled blood collection tubes in a laboratory with red, purple, and green caps.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 30, 2026 / 12 sources

Insulin pen and its packaging are shown.

Daily Briefing

September 29, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 29, 2026 / 10 sources

High Blood Sugar glucose over 200mg Test Results Readings Meter, 1/2015 by Mike Mozart of TheToyChannel and JeepersMedia on YouTube #High #Blood #Sugar #Glucose

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 29, 2026 / 10 sources

Flat lay of diabetes tools, green apple, almonds, and notebook for health planning.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 29, 2026 / 6 sources

Unrecognizable man wearing medical uniform with stethoscope and pens standing in hospital with crossed arms during work in day time

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 29, 2026 / 10 sources

Female scientist working with test tubes and microscope in a laboratory.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 29, 2026 / 12 sources

Close-up of a researcher using tweezers to work with a petri dish in a lab setting.

Daily Briefing

September 28, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 28, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 28, 2026 / 10 sources

Elderly man in a gym stretching with a fitness coach, promoting a healthy lifestyle.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 28, 2026 / 6 sources

Nurse attends to patient with doctor observing

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 28, 2026 / 10 sources

Scientific Research Institute of Lung Diseases of the Ministry of Health of the Republic of Azerbaijan

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 28, 2026 / 12 sources

Researchers in a lab examining test tubes with colored liquids for experiments.

Daily Briefing

September 27, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 27, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 27, 2026 / 10 sources

Close-up of a syringe and medical gloves on a flat surface, showcasing healthcare tools.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 27, 2026 / 6 sources

Medical professional wearing gloves preparing patient for blood draw using a tourniquet.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 27, 2026 / 10 sources

Researchers using a microscope and taking notes in a modern lab.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 27, 2026 / 12 sources

Laboratory scientist conducts an experiment with a Rotary evaporator

Daily Briefing

September 26, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 26, 2026 / 10 sources

person using disposable syringe put specimen on blue and white glucose meter

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 26, 2026 / 10 sources

Flat lay image of healthcare essentials including a blood pressure monitor, pills, and eyeglasses on a white surface.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 26, 2026 / 6 sources

A patient is reflected in a sphygmomanometer during a medical appointment, highlighting the focus on healthcare.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 26, 2026 / 10 sources

A female scientist in a lab coat examines samples under a microscope for research.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 26, 2026 / 12 sources

File:West Nile Vaccine Research in BSL-3 Lab.jpg

Daily Briefing

September 25, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 25, 2026 / 10 sources

A blue insulin pen rests on a white surface

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 25, 2026 / 10 sources

the word mental health spelled with scrabbles next to a green leaf

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 25, 2026 / 6 sources

A modern hospital room featuring advanced medical equipment with digital displays.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 25, 2026 / 9 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 25, 2026 / 12 sources

File:Glasgow clinical research facility.png

Daily Briefing

September 24, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 24, 2026 / 10 sources

Bottle of dextrotabs for glucose and glucose

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 24, 2026 / 10 sources

Adult female using a medical weighing scale in a healthcare setting.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 24, 2026 / 6 sources

A doctor performs an eye examination on a patient in a clinical setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 24, 2026 / 10 sources

Army scientists energize battery research

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 24, 2026 / 12 sources

Daily Briefing

September 23, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 23, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 23, 2026 / 10 sources

Syringe and vaccine vials arranged on gray surface, symbolizing healthcare and immunization.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 23, 2026 / 6 sources

Nurse uses digital tablet for patient consultation and diagnosis in a clinical setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 23, 2026 / 10 sources

Portrait, microscope, laboratory, test tube, scale, burette Fortepan 7166

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 23, 2026 / 12 sources

Detailed view of a semaglutide injection pen, commonly used for diabetes treatment, on a plain background.

Daily Briefing

September 22, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 22, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 22, 2026 / 10 sources

Detailed close-up of vibrant blue gel capsules symbolizing medical and healthcare treatments.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 22, 2026 / 6 sources

A blood bag with a drip chamber hanging in a clinical setting

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 22, 2026 / 9 sources

A scientist carefully examining samples using a microscope in a modern laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 22, 2026 / 12 sources

Scientists from South Africa training on mRNA Vaccine Production at the NIAID Vaccine Research Center

Daily Briefing

September 21, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 21, 2026 / 10 sources

A yellow medical sensor attached to a person's arm

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 21, 2026 / 10 sources

Colorful vegan salads featuring fresh vegetables in close-up for healthy eating inspiration.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 21, 2026 / 6 sources

Duke Clinical Research Institute, Durham, North Carolina

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 21, 2026 / 10 sources

Detailed view of a scientist operating a microscope in a laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 21, 2026 / 12 sources

Naval Medical Research Center labs support Operation United Assistance

Daily Briefing

September 20, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 20, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 20, 2026 / 10 sources

Refreshing breakfast arrangement with fruit, nuts, and tea for a healthy start.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 20, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 20, 2026 / 10 sources

Barbara McClintock (1902-1992), Department of Genetics, Carnegie Institution at Cold Spring Harbor, New York, shown in her laboratory. This photograph was distr

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 20, 2026 / 12 sources

A young female scientist with curly hair in a lab coat working in a laboratory setting.

Daily Briefing

September 19, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 19, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 19, 2026 / 10 sources

Black drongo (Dicrurus macrocercus) with it's healthy meal, Padma river, Rajshahi

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 19, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 19, 2026 / 10 sources

A scientist works with a microscope in a bright, modern lab setting, wearing a lab coat.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 19, 2026 / 12 sources

Daily Briefing

September 18, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 18, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 18, 2026 / 10 sources

Bunches of healthy dill and fresh lettuce placed near heap of green onions on stall in grocery market during harvest season

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 18, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 18, 2026 / 10 sources

a microscope with a microscope attached to it

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 18, 2026 / 12 sources

Detailed view of laboratory glass vials held by a clamp with red handles, ideal for science stock images.

Daily Briefing

September 17, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 17, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 17, 2026 / 10 sources

Women exercising with resistance bands in a well-lit rustic studio, promoting fitness and health.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 17, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 17, 2026 / 10 sources

A Meiji Techno microscope with multiple objective lenses above a black stage

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 17, 2026 / 12 sources

A scientist in a white lab coat using a laptop in a laboratory

Daily Briefing

September 16, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 16, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 16, 2026 / 10 sources

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 16, 2026 / 6 sources

Doctor examining patient's eyes with equipment

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 16, 2026 / 10 sources

20160926 Clinical Research Centre Malmo 0058 (29343224923)

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 16, 2026 / 12 sources

Daily Briefing

September 15, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 15, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 15, 2026 / 10 sources

Close-up of a healthcare professional measuring an infant using a medical ruler.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 15, 2026 / 6 sources

A medical professional checking patient reports with a clipboard in an office setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 15, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 15, 2026 / 12 sources

File:Dominique Wilkins speaks to an attentive group at the Diabetes Living Room in Philadelphia.jpg

Daily Briefing

September 14, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 14, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 14, 2026 / 10 sources

A female doctor uses a stethoscope to listen to a young boy's heartbeat, conducting a health check outdoors.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 14, 2026 / 6 sources

A doctor holds a pill bottle while consulting with an elderly patient. A stethoscope and prescriptions are visible.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 14, 2026 / 10 sources

Prorew medical laboratory and Diagnostics

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 14, 2026 / 12 sources

European Molecular Biology Laboratory (EMBL) - July 2022 10

Daily Briefing

July 1, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

July 1, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

July 1, 2026 / 10 sources

Two adults cooking fresh vegetables on a stove, preparing a healthy meal in a modern kitchen.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

July 1, 2026 / 6 sources

Patients To Benefit From New Technology (40779081165)

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

July 1, 2026 / 10 sources

Microhaematocrit Centrifuge; from a medical laboratory in Abuja, Nigeria

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

July 1, 2026 / 12 sources